GlassScriptPhysician profile
Jason D Perelman
NPI 1588659205
$11,187.29
in general payments reported to CMS, 2019-2025
39 companies · $1,001 in 2025
The $1,001 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $579 · 2021: $1,640 · 2022: $4,654 · 2023: $1,721 · 2024: $1,005 · 2025: $1,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,480 · Travel and Lodging: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,479.64 |
| Travel and Lodging | $247.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $3,792.58 | 2019-2023 | Xtandi, Myrbetriq |
| Myriad Genetic Laboratories, INC. | $936.20 | 2021-2025 | Prolaris, Myrisk |
| Janssen Biotech, INC. | $704.47 | 2019-2025 | Erleada |
| Olympus America INC. | $677.97 | 2020-2025 | Soltive, Gyrus Acmi, Itind System |
| Pfizer INC. | $582.37 | 2019-2025 | |
| Procept Biorobotics Corporation | $578.88 | 2023-2025 | Aquabeam Robotic System |
| Rochester Medical Corporation | $537.05 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $289.86 | 2022-2025 | |
| Antares Pharma, INC. | $288.50 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $256.37 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $250.69 | 2020-2024 | |
| Tolmar Pharmaceuticals, INC. | $234.84 | 2019-2022 | |
| Myovant Sciences INC. | $228.85 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $210.48 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $165.04 | 2019-2025 | Adstiladrin |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Perelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.